Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Harvard Business Review3d
When Your Coworkers Got Laid Off — But You Didn’t
Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.
STAT4d
Lawmakers ask FDA to review Hims’ Super Bowl ad for ‘misleading’ patients
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...
Why Trump’s threatened pharmaceutical tariffs would be unlikely to lower prices in the U.S.
U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...
BioPharma Dive11d
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
Becker's Hospital Review5d
Keytruda's looming patent expiry raises concerns: 5 notes
Merck & Co.'s heavy reliance on its cancer drug Keytruda, which accounts for nearly half of the company's revenue, is raising investor concerns as the drug's patent expiration approaches in 2028, The ...
Legislators try again to create state board to review drug prices
For five years now, a bipartisan group of Illinois lawmakers have wanted to establish a Prescription Drug Affordability Board. But this year's effort may hit the same wall as before.